We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Declines While Market Improves: Some Information for Investors
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed at $14.20 in the latest trading session, marking a -10.52% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.07% for the day. On the other hand, the Dow registered a loss of 0.7%, and the technology-centric Nasdaq increased by 0.18%.
Shares of the company witnessed a loss of 17.3% over the previous month, trailing the performance of the Finance sector with its gain of 4.82%, and the S&P 500's gain of 5.71%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 6, 2025. The company is forecasted to report an EPS of -$0.51, showcasing a 355% downward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $2.79 billion, up 25.56% from the prior-year quarter.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of -$0.68 per share and revenue of $12.04 billion. These results would represent year-over-year changes of -780% and +31.14%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 211.41% lower within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #4 (Sell).
Investors should also note Oscar Health, Inc.'s current valuation metrics, including its Forward P/E ratio of 58.06. This denotes a premium relative to the industry average Forward P/E of 10.28.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 164, finds itself in the bottom 34% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Declines While Market Improves: Some Information for Investors
Oscar Health, Inc. (OSCR - Free Report) closed at $14.20 in the latest trading session, marking a -10.52% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.07% for the day. On the other hand, the Dow registered a loss of 0.7%, and the technology-centric Nasdaq increased by 0.18%.
Shares of the company witnessed a loss of 17.3% over the previous month, trailing the performance of the Finance sector with its gain of 4.82%, and the S&P 500's gain of 5.71%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 6, 2025. The company is forecasted to report an EPS of -$0.51, showcasing a 355% downward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $2.79 billion, up 25.56% from the prior-year quarter.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of -$0.68 per share and revenue of $12.04 billion. These results would represent year-over-year changes of -780% and +31.14%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 211.41% lower within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #4 (Sell).
Investors should also note Oscar Health, Inc.'s current valuation metrics, including its Forward P/E ratio of 58.06. This denotes a premium relative to the industry average Forward P/E of 10.28.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 164, finds itself in the bottom 34% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.